|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:272-277, doi:10.1016/j.jacc.2004.09.059 © 2005 by the American College of Cardiology Foundation |
Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China
Manuscript received July 15, 2004; accepted September 29, 2004.
* Reprint requests and correspondence: Dr. John E. Sanderson, 9/F, Clinical Sciences Building, Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China (Email: jesanderson{at}cuhk.edu.hk).
| Abstract |
|---|
|
|
|---|
BACKGROUND: The early diastolic mitral annulus velocity (Em) reflects myocardial relaxation, and the combined ratio of the early transmitral flow velocity (E) to Em (E/Em) >15 correlates well with elevated mean LVDP. It is unknown if these new indexes will predict poorer survival in patients with LV systolic dysfunction.
METHODS: Echocardiograms were prospectively obtained in 182 patients with impaired LV systolic function, defined as an LV ejection fraction <0.50. The end point was cardiac mortality. The majority of this patient sample (80%) has been reported on in a previous publication.
RESULTS: After a median 48 months' follow-up, Em emerged as an independent predictor of survival (hazard ratio 0.61, 95% confidence interval 0.45 to 0.82). An Em <3 cm/s was associated with a significantly excess mortality (log-rank statistic 9.36, p = 0.002), and this measurement added incremental prognostic value to standard indexes of systolic or diastolic function, including a deceleration time <140 ms and an E/Em >15 (p = 0.038).
CONCLUSIONS: Early diastolic mitral annulus velocity is a powerful predictor of cardiac mortality in patients with LV systolic impairment; Em <3 cm/s emerged as the best prognosticator in long-term follow-up, incremental to other clinical or echocardiographic variables, including the ratio E/Em.
| |||||||||||
Using tissue Doppler imaging (TDI), myocardial velocities at the mitral annulus have been shown to be useful for quantifying global systolic and diastolic LV function (8). The early diastolic myocardial velocity (Em), in particular, reflects myocardial relaxation and is relatively load-independent (9). In addition, the ratio of early transmitral flow velocity (E) to early diastolic septal mitral annulus velocity (E/Em) correlates well with mean LV diastolic pressure (10) and has recently been shown to be a powerful independent predictor of all-cause mortality after acute myocardial infarction (11). In a previous study, we found that an Em value <3 cm/s provides incremental prognostic value for predicting cardiac mortality in patients with a variety of cardiovascular diseases (12). However, it is uncertain if Em alone has prognostic value in patients with systolic dysfunction or if the ratio E/Em is superior. To test this hypothesis, we evaluated the prognostic value of Em in a large series of unselected patients with impaired LV systolic function and compared this with other established clinical, systolic, and diastolic parameters, including the ratio E/Em.
| Methods |
|---|
|
|
|---|
Echocardiography. Echocardiograms were obtained using General Electric VingMed Sound AB (Horten, Norway) with a 3.5-MHz transducer. Methods of acquiring two-dimensional Doppler, TDI, and their measurements were as previously described (12). All recordings were performed by one investigator (M.W.). Left atrial maximal volume (LAVmax) was traced at the end of systole from apical four- and two-chamber views. Abnormal diastolic function was categorized into abnormal relaxation filling pattern, pseudonormal filling pattern, and restrictive filling pattern according to Garcia et al. (13). We used average value of myocardial velocities measured at septal, lateral, inferior, and anterior aspect as previously described. Peak velocities during systole (Sm), early diastole (Em), and late diastole (Am) were measured.
Outcome measurements. Death and mode of death were identified from hospital records or telephone interviews with relatives. Cardiac death was defined as death caused by heart disease, including sudden death.
Statistics analysis. Continuous data are expressed as mean values ± SD, and comparisons between groups were tested by unpaired t test. Categorical data are presented as absolute values and percentages, and comparisons were tested by Fisher exact test. Estimations of risk were performed using Cox proportional hazard models by univariate and multivariate analysis. Patients who died from other causes or were lost to follow-up were censored.
The incremental value of TDI over clinical data and transmitral inflow variables was assessed in four modeling steps in the same order as in clinical practice. The first step consisted of clinical data used as baseline risk factors. Transmitral inflow variable was then added in the next block. The third block was E/Em >15. In the final step, TDI variables were added. A significant improvement in model prediction was based on the likelihood ratio statistic, which follows a chi-square distribution, and the p value was based on the incremental value compared with the previous model.
Cumulative survival curve was performed by Kaplan-Meier method, and mortality rates were compared using the log-rank test. SPSS version 11.5 (SPSS Inc., Chicago, Illinois) was used for all analyses.
| Results |
|---|
|
|
|---|
3 and Em <3 cm/s are shown in Table 2.
|
|
3. Patients with Em <3 had worse LVEF, lower E, reduced Sm, and higher E/Em. In addition, of those with Em <3, 94% had an E/Em >15. However, there was no difference in LAVmax and the prevalence of moderate or severe mitral regurgitation between the two groups. Predictors and outcome. All patients were followed for a median of 48 months (range 0.3 to 68 months); 36 patients (20%) died of a cardiac cause. A history of ischemic heart disease, valvular heart disease, or heart failure were the most common baseline diagnoses in those who died (Table 3). In addition, 12 patients died due to other causes such as bacterial septicemia, cancer, or unknown.
|
140 ms, the prognostic utility of an Em <3 did not attain statistical significance (n = 44, log-rank = 1.48, p = 0.22), which was likely due to the insufficient numbers of events. However, there was a trend showing more patients with Em <3 died after one-year of follow-up. When patients were stratified on the basis of their E/Em, Em <3 still predicted increased cardiac mortality even in patients with an E/Em
15 (n = 141, log-rank = 5.15, p = 0.02). Of 32 patients with an E/Em <15, only one patient died who had an Em >3. Thus, the combination of an E/Em <15 and Em >3 cm/s predicted a more favorable outcome.
|
140 were associated with cardiac death. In multivariate Cox regression, backward stepwise analysis adjusted by age, Sm, Em, Am, E/Em, and DT, Em remained the strongest predictor for cardiac death (0.61, 95% confidence interval: 0.45 to 0.82).
The incremental value of an Em <3 is shown in Figure 2; E/Em >15 improved the prognostic value of a model containing clinical risk factors and DT
140 (p = 0.05). However, Em <3 significantly improved the outcome of a mode that contained clinical risk factors, DT
140 and E/Em >15 (p = 0.038).
|
3, respectively. In contrast, patients with Em <3 tended to receive more aspirin (67% vs. 49%, p = 0.03) and beta-blockers (52% vs. 36%, p = 0.05). In our study group, medication was not predictive of subsequent mortality. | Discussion |
|---|
|
|
|---|
140 ms and E/Em >15. LV filling pressure and prognosis. Elevated LV filling pressure is associated with increased mortality in dilated cardiomyopathy (3,14) and after acute myocardial infarction (15,16). A short DT correlates well with elevated left atrial pressure, especially in patients with impaired LV systolic function (7,10) and is an independent predictor of adverse outcome in patients with acute myocardial infarction (17). Our study reaffirms the prognostic value of a short DT in patients with subnormal LVEF.
Incremental value of E/Em. However, an elevated E/Em is a more powerful prognostic indicator than transmitral flow variables. Our calculated E/Em appears to be higher than previously reported. In our study, Em was a mean value taken from four different LV annular sites and was measured after post-processing of the color Doppler data that contained mean velocities. This is in contrast with the velocities recorded by pulsed Doppler where peak instantaneous velocities are measured in the sample volume and are usually recorded only at the septal mitral annulus. The off-line values are generally about 15% to 20% lower than those obtained by pulsed Doppler (18) and would explain why the ratio E/Em is higher.
Incremental value of Em. The current study shows that, after a median follow-up of 48 months, Em gradually emerged as the best predictor of cardiac survival with Em <3 cm/s adding incremental prognostic data to clinical and standard echocardiographic parameters. This long-term study further supports our previous work in a more general group of cardiac patients that Em, among other TDI variables, was the strongest predictor of cardiac mortality (12); Em correlates closely with the time constant of isovolumic relaxation (tau) and is relatively insensitive to preload changes in the presence of LV systolic dysfunction (9), and this may explain why Em is a good indicator of function and outcome. Furthermore, abnormalities of diastolic function are often more sensitive indicators of overall ventricular function (19). Therefore, measurements of E/Em and Em should be routinely performed in patients with reduced LV systolic function, not merely for estimating the LV filling pressure and the degree of impairment of myocardial relaxation but, more importantly, for assessing prognosis and risk stratification.
Study limitations. This cohort has a relatively high prevalence of patients suffering from hypertension (51%) with approximately equal prevalence of coronary artery disease (38%) and diabetes mellitus (35%). However, it represents a consecutive series of patients and may simply confirm our previous data that hypertension was the most common associated risk factor for congestive heart failure in Hong Kong (20) and that itself alone or in combination with coronary artery disease was the most common condition predating the onset of heart failure (21).
Our study end point was cardiac mortality including sudden death. It is assumed that this is due to a cardiac arrhythmia, although this cannot be proved conclusively.
Conclusions. The current data demonstrate that Em is a powerful predictor of survival in patients with LV systolic impairment; Em <3 cm/s emerges as the best prognosticator in long-term follow-up, incremental to other clinical or echocardiographic variables, including the E/Em. This easily acquired diastolic index assists in stratifying cardiovascular risk in this group of patients.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Y-M. Wang, M. Wang, C. W-K. Lam, I. H-S. Chan, Y. Zhang, and J. E. Sanderson Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Hypertension, July 1, 2008; 52(1): 107 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
G W K Yip, M Wang, T Wang, S Chan, J W H Fung, L Yeung, T Yip, S-T Lau, C-P Lau, M-O Tang, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction Heart, May 1, 2008; 94(5): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lancellotti, B. Cosyns, and L. A. Pierard Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure Europace, April 1, 2008; 10(4): 496 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Tartiere, D. Logeart, L. Tartiere-Kesri, and A. Cohen-Solal Colour tissue Doppler underestimates myocardial velocity as compared to spectral tissue Doppler: Poor reliability between both methods Eur J Echocardiogr, March 1, 2008; 9(2): 268 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Abraham, V. L. Dimaano, and H.-Y. Liang Role of Tissue Doppler and Strain Echocardiography in Current Clinical Practice Circulation, November 27, 2007; 116(22): 2597 - 2609. [Full Text] [PDF] |
||||
![]() |
C.-M. Yu, J. E. Sanderson, T. H. Marwick, and J. K. Oh Tissue Doppler Imaging: A New Prognosticator for Cardiovascular Diseases J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1903 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tumminello, P. Lancellotti, M. Lempereur, V. D'Orio, and L. A. Pierard Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure Eur. Heart J., March 1, 2007; 28(5): 569 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Sanderson Heart failure with a normal ejection fraction Heart, February 1, 2007; 93(2): 155 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Okura, Y Takada, T Kubo, K Iwata, S Mizoguchi, H Taguchi, I Toda, J Yoshikawa, and K Yoshida Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation Heart, September 1, 2006; 92(9): 1248 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Chen, M. J. Wood, D. G. Krauser, A. L. Baggish, R. Tung, S. Anwaruddin, M. H. Picard, and J. L. Januzzi NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy Eur. Heart J., April 1, 2006; 27(7): 839 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Weyman The Year in Echocardiography J. Am. Coll. Cardiol., February 21, 2006; 47(4): 856 - 863. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |